Meet The Researcher

Professor Trevor Kilpatrick

Florey Institute of Neuroscience and Mental Health

What inspired you to get involved in MS research?
The idea that there was a real possibility of making a meaningful contribution to the lives of people with MS during my scientific career.
What do you think has been the most exciting development in MS research?
Undoubtedly, the advent of immunomodulatory therapies that unequivocally benefit people with relapsing remitting disease. We now need to extend those advances to make sure that people with progressive MS also benefit.
Why is your research important and how will it influence the understanding and treatment of MS?
The cellular therapy we will develop could be very effective as it targets key initiating events in MS and it could treat all disease stages. In particular, the targeted cells are mobile and could traverse to the central nervous system to inhibit disease causing immune cells resident within the CNS, otherwise hidden from current drug therapies. Furthermore, the approach is practicable as it is in early phase clinical trials for treatment of other diseases such as diabetes, so the work will be eminently translatable to trials in people with MS.
What do you enjoy most about working in the lab and what are some of the challenges you face?
I enjoy contributing to new discoveries and working out how that new knowledge can be harnessed for people's benefit. One of the key challenges is for everyone to remain committed for the long haul; translation from discovery to implementation, unfortunately, does take time.
Read More

Newsletter subscription

  • Enter your details

Professor Trevor Kilpatrick